High Earners Are Betting They Can Do Better Than Maxing Out Their 401(k)s

Rivercell, a Paris-based BioTech and AI company building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment, has launched today out of stealth with a €22 million ($25 million) Seed round.The round was led by HV, with participation from HCVC, Alven and Bpifrance Digital Venture. The investment will fund the scale-up of Rivercell’s prop